Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
11 10 Search
2025
Harnessing Actinobacteria secondary metabolites for tuberculosis drug discovery: Historical trends, current status and future outlooks
Natural Products and Bioprospecting
2025
Repurposing eugenol and cinnamaldehyde as potent antimicrobial agents: A comprehensive in-vitro and in-silico study
Bioorganic Chemistry
2025
ActO, a positive cluster-situated regulator for actinomycins biosynthesis in Streptomyces antibioticus ZS
Gene
2024
Exploring Indonesian actinomycete extracts for anti-tubercular compounds: Integrating inhibition assessment, genomic analysis, and prediction of its target by molecular docking
Heliyon
2024
Control of citrus blue and green molds by Actinomycin X2 and its possible antifungal mechanism
Pesticide Biochemistry and Physiology
2024
In silico drug design strategies for discovering novel tuberculosis therapeutics
Expert Opinion on Drug Discovery
2024
Natural products can be potential inhibitors of metalloproteinase II from Bacteroides fragilis to intervene colorectal cancer
Heliyon
2024
Microbial-derived peptides with anti-mycobacterial potential
European Journal of Medicinal Chemistry
2024
Antibacterial Mechanism, Control Efficiency, and Nontarget Toxicity Evaluation of Actinomycin X2 against Xanthomonas citri Subsp. citri
Journal of Agricultural and Food Chemistry
2023
Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study
Frontiers in Pharmacology
Additional cited-by details will be shown when available from Crossref